Skip to content

Innoviva, Inc. INVA Deferred Taxes

Deferred Taxes at other companies

Pfizer logo
PfizerPFE
-$12M+98.2%
Merck & Co. logo
Merck & Co.MRK
-$315M-69.4%
AbbVie logo
AbbVieABBV
$137M+589%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$13.53M+53.0%
Organon logo
OrganonOGN
$3M+118%
Alkermes logo
AlkermesALKS

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s deferred taxes?
Innoviva, Inc. (INVA) reported deferred taxes of $41.04M in Q1 2026.
How has Innoviva, Inc.'s deferred taxes changed year-over-year?
Innoviva, Inc.'s deferred taxes increased by 17199.2% year-over-year, from -$240K to $41.04M.
What is the long-term trend for Innoviva, Inc.'s deferred taxes?
Over 2 years (2021 to 2025), Innoviva, Inc.'s deferred taxes has grown at a -24.3% compound annual growth rate (CAGR), from $76.43M to $43.85M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.